Astria Therapeutics, Inc. (ATXS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Assets
Current assets:
Cash and cash equivalents	134.0	202.3	20.5	46.0	29.8	46.7	86.5	131.8
Short-term investments	69.0	11.0	205.9	70.6	72.7	66.1	39.0
Prepaid expenses and other current assets	1.5	2.1	1.3	1.9	1.3	1.4	1.6	2.7
Total current assets	204.4	215.4	227.7	118.5	103.8	114.2	127.1	134.5
Right-of-use asset	0.7	0.8	0.9	1.1	1.3	0.2	0.4	0.6
Other assets	2.0	2.0	2.0	0.2	0.2	0.2	0.0	0.1
Total assets	207.1	218.2	230.6	119.8	105.3	114.7	127.5	135.1

Liabilities and stockholders' equity
Current liabilities:
Accounts payable	0.8	0.9	0.8	0.8	1.0	0.9	1.6	0.6
Accrued expenses	5.2	5.2	7.7	5.1	3.7	3.9	3.3	3.6
Current portion of operating lease liabilities	0.6	0.6	0.6	0.6	0.6	0.2	0.4	0.5
Total current liabilities	6.6	6.7	9.1	6.4	5.2	5.0	5.2	4.7
Long term portion of operating lease liabilities	0.1	0.2	0.4	0.5	0.6
Total liabilities	6.7	6.9	9.4	6.9	5.9	5.0	5.2	4.7

Commitments
Stockholders' equity:
Preferred stock, $0.001 par value per share, 4,908,620 shares authorized and no shares issued and outstanding
Common stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	636.4	634.8	632.5	511.1	485.6	484.5	481.7	480.3
Accumulated other comprehensive loss		0.0	-0.1	-0.2	-0.2	-0.1
Accumulated deficit	-531.4	-518.8	-507.6	-494.4	-482.4	-471.1	-455.8	-446.3
Total stockholders' equity	200.4	211.4	221.2	112.9	99.4	109.7	122.3	130.4
Total liabilities and stockholders' equity	207.1	218.2	230.6	119.8	105.3	114.7	127.5	135.1